BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30218622)

  • 1. Clinicocytopathological spectrum, including uncommon forms, of nine cases of chordomas with immunohistochemical results, including brachyury immunostaining: A single institutional experience.
    Rekhi B; Karmarkar S
    Cytopathology; 2019 Mar; 30(2):229-235. PubMed ID: 30218622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomorphological spectrum, including immunohistochemical results of 16 cases of clear cell sarcoma of soft tissue, along with positive EWSR1 gene rearrangement result in two cases.
    Rao V; Rekhi B
    Cytopathology; 2020 Jul; 31(4):280-287. PubMed ID: 32356379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
    Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
    Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary, large extra-axial chordoma in proximal tibia: a rare case report with literature review and diagnostic implications.
    Rekhi B
    APMIS; 2016 Mar; 124(3):238-42. PubMed ID: 26522887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting cytomorphology, including unusual features and clinical scenarios of 8 cases of alveolar soft part sarcoma with TFE3 immunohistochemical staining in 7 cases.
    Rekhi B; Rao V; Ramadwar M
    Cytopathology; 2021 Jan; 32(1):20-28. PubMed ID: 32853443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parapharyngeal chordoma: a diagnostic challenge and potential mimic of pleomorphic adenoma on fine-needle aspiration cytology.
    Castro M; Aslan D; Manivel JC; Pambuccian SE
    Diagn Cytopathol; 2013 Jan; 41(1):85-91. PubMed ID: 22102517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
    Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
    Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chordoma: Immunohistochemical Analysis of Brachury.
    Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
    Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-needle aspiration cytology of sacrococcygeal chordoma.
    Nijhawan VS; Rajwanshi A; Das A; Jayaram N; Gupta SK
    Diagn Cytopathol; 1989; 5(4):404-7. PubMed ID: 2612318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
    Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
    Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squash smear and fine needle aspiration features of conventional chordoma.
    Gajdzis P; Klijanienko J; Gajdzis M
    Cytopathology; 2023 Sep; 34(5):503-506. PubMed ID: 36840426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
    Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM
    J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chordoma: a cytologic study with histologic and radiologic correlation.
    Crapanzano JP; Ali SZ; Ginsberg MS; Zakowski MF
    Cancer; 2001 Feb; 93(1):40-51. PubMed ID: 11241265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chordoma. Cytomorphologic findings in 14 cases diagnosed by fine needle aspiration.
    Kay PA; Nascimento AG; Unni KK; Salomão DR
    Acta Cytol; 2003; 47(2):202-8. PubMed ID: 12685190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma.
    Zhang L; Guo S; Schwab JH; Nielsen GP; Choy E; Ye S; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    PLoS One; 2013; 8(9):e75851. PubMed ID: 24086644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Diagnostic Pitfall: Atypical Teratoid Rhabdoid Tumor Versus Dedifferentiated/Poorly Differentiated Chordoma: Analysis of a Mono-institutional Series.
    Buccoliero AM; Caporalini C; Scagnet M; Baroni G; Moscardi S; Mussa F; Giordano F; Sardi I; Genitori L
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):147-154. PubMed ID: 28777153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chordoma: analysis of 47 fine-needle aspiration biopsy, cytologic imprint, and small biopsy specimens.
    Wakely PE; Saoud C; Ali SZ
    J Am Soc Cytopathol; 2023; 12(1):30-40. PubMed ID: 36270910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.